US stocks look set to open lower Friday amid a stream of earnings reports released premarket and set for release after the day's market hours, as well as the University of Michigan's consumer sentiment and expectations index readings coming out later in the morning.
Dow Jones Industrial Average futures were down 0.4%, S&P 500 futures were off 0.2%, and Nasdaq futures were moving 0.3% lower.
Oil prices were dropping sharply, with front-month global benchmarks North Sea Brent crude down 0.9% at $65.05 per barrel and US West Texas Intermediate crude falling 0.9% to $62.20 per barrel.
Both the Michigan Consumer Sentiment and the Michigan Consumer Expectations indices for April are expected to fall, with the former expected to decline to 50.8 from 57.0 from March, while the latter is forecast to slide to 47.2 from 52.6, according to Bloomberg.
In other world markets, Japan's Nikkei surged 1.9%, Hong Kong's Hang Seng was up 0.3%, and China's Shanghai Composite was off 0.07%. Meanwhile in Europe's early afternoon session, the UK's FTSE 100 gained 0.2%, while Germany's DAX was up 0.8%, France's CAC 40 was up 0.6% and Spain's IBEX 35 was up 1.3%.
In equities, shares of Odyssey Marine Exploration (OMEX) jumped 77%, adding to a 100% gain the previous session. SES AI (SES) shares were up 34% after it said overnight that its board authorized it to buy back up to $30 million of its Class A common stock. Pony AI (PONY) stock was 27% higher after the company said it signed a collaboration with Tencent Cloud and Smart Industries Group for autonomous driving technology and commercialization of Robotaxi services. Cantor Equity Partners (CEP) shares advanced 19%, after surging 50% on Thursday. And shares of American Rebel (AREB) climbed 9.2%, adding to a 28% gain the previous day.
On the losing side, shares of Intensity Therapeutics (INTS) lost 31% after it priced a public offering stocks and accompanying common warrants at combined price of $0.75 each. Saia (SAIA) shares were down 23% after reporting lower Q1 earnings compared with a year earlier. BriaCell Therapeutics (BCTX) shares dropped 23% after it said Friday that it priced a public offering of 3.07 million units at $4.50 each for gross proceeds of about $13.8 million. And shares of Wag! Group (PET) lost 19%, eating half of Thursday's 38% gain.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.